1. Home
  2. Analysis
  3. Procysbi
  4. Disease-progression

Procysbi and Disease progression - a phase IV clinical study of FDA data

Summary:

Disease progression is reported as a side effect among people who take Procysbi (cysteamine bitartrate), especially for people who are male, 10-19 old, also take Cystagon, and have Cystinosis.

The phase IV clinical study analyzes which people have Disease progression when taking Procysbi. It is created by eHealthMe based on reports of 998 people who have side effects when taking Procysbi from the FDA, and is updated regularly.

What is Procysbi?

Procysbi has active ingredients of cysteamine bitartrate. eHealthMe is studying from 998 Procysbi users. Check the latest studies of Procysbi.

What is Disease progression?

Disease progression is found to be associated with 1,800 drugs and 2,254 conditions by eHealthMe. Check the latest studies of Disease progression.

On Jul, 21, 2026

998 people reported to have side effects when taking Procysbi.
Among them, 12 people (1.2%) have Disease progression.

Could Procysbi cause Disease progression?

Among these 12 people:

What is the gender of people who have Disease progression when taking Procysbi? *

  • female: 42.86 %
  • male: 57.14 %

What is the age of people who have Disease progression when taking Procysbi? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 60 %
  • 20-29: 40 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Procysbi? *

  1. Vasotec: 5 people, 41.67%
  2. Tacrolimus: 5 people, 41.67%
  3. Synthroid: 5 people, 41.67%
  4. Procainamide Hydrochloride: 5 people, 41.67%
  5. Myfortic: 5 people, 41.67%
  6. Cystagon: 5 people, 41.67%
  7. Vitamin D: 2 people, 16.67%
  8. Tylenol: 2 people, 16.67%
  9. Zofran: 1 person, 8.33%

What are other side effects people have besides Disease progression? *

  1. Cystinosis (abnormal accumulation of the amino acid cystine): 9 people, 75.00%
  2. Muscle Aches (muscle pain): 5 people, 41.67%
  3. Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 5 people, 41.67%
  4. Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 5 people, 41.67%
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 41.67%
  6. Cough: 5 people, 41.67%
  7. Dizziness: 5 people, 41.67%
  8. Fatigue (feeling of tiredness): 5 people, 41.67%
  9. Head Injury: 5 people, 41.67%
  10. Headache (pain in head): 5 people, 41.67%

What are the existing conditions these people have? *

  1. Cystinosis (abnormal accumulation of the amino acid cystine): 12 people, 100.00%
  2. Pain: 2 people, 16.67%
  3. Nausea (feeling of having an urge to vomit): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Procysbi and have Disease progression?

- Check whether Disease progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Procysbi:

Disease progression treatments and more:

How severe was Disease progression and when was it recovered:

Expand to all the drugs that have ingredients of cysteamine bitartrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Procysbi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease progression:

Browse all the conditions that are associated with Disease progression:

How the study uses the data?

The study uses data from the FDA. It is based on cysteamine bitartrate (the active ingredients of Procysbi) and Procysbi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.